1. N-Glycoside of Indolo[2,3-a]pyrrolo[3,4-c]carbazole LCS1269 Exerts Anti-Glioblastoma Effects by G2 Cell Cycle Arrest and CDK1 Activity Modulation: Molecular Docking Studies, Biological Investigations, and ADMET Prediction
   Nikolay Kalitin et al, 2024, Pharmaceuticals CrossRef
2. Implementation of a combined CDK inhibition and arginine-deprivation approach to target arginine-auxotrophic glioblastoma multiforme cells
   Christin Riess et al, 2022, Cell Death & Disease CrossRef
3. Therapeutic Efficacy of Roscovitine Against Cancer
   Sarita Das, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
4. Inhibitory effects of resveratrol on hepatitis B virus X protein-induced hepatocellular carcinoma
   Seungmo Park et al, 2017, Journal of Veterinary Science CrossRef
5. Anticancer Activity of Natural Compounds from Plant and Marine Environment
   Anna Lichota et al, 2018, International Journal of Molecular Sciences CrossRef
6. Cell-cycle-gated feedback control mediates desensitization to interferon stimulation
   Anusorn Mudla et al, 2020, eLife CrossRef
7. Roscovitine Protects From Arterial Injury by Regulating the Expressions of c-Jun and p27 and Inhibiting Vascular Smooth Muscle Cell Proliferation
   Yu Liu et al, 2017, Journal of Cardiovascular Pharmacology CrossRef
8. Enzalutamide-induced signatures revealed by epigenetic plasticity using single-cell multi-omics sequencing in prostate cancer
   Huihui Fan et al, 2023, Molecular Therapy - Nucleic Acids CrossRef
9. Therapeutic Efficacy of Roscovitine Against Cancer
   Sarita Das, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
10. Cyclin-dependent kinase inhibitors, roscovitine and purvalanol, induce apoptosis and autophagy related to unfolded protein response in HeLa cervical cancer cells
    Pelin Ozfiliz-Kilbas et al, 2018, Molecular Biology Reports CrossRef
11. Cyclin-dependent kinase inhibitors in head and neck cancer and glioblastoma—backbone or add-on in immune-oncology?
    Christin Riess et al, 2021, Cancer and Metastasis Reviews CrossRef
12. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors
    Abeer M. El-Naggar et al, 2021, Bioorganic Chemistry CrossRef
13. Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer
    Justyna Magdalena Hermanowicz et al, 2021, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
14. Roscovitine protects murine Leydig cells from lipopolysaccharide-induced inflammation
    Tiancheng Xie et al, 2017, Experimental and Therapeutic Medicine CrossRef
15. Roscovitine effectively enhances antitumor activity of temozolomide in vitro and in vivo mediated by increased autophagy and Caspase-3 dependent apoptosis
    Vimal Pandey et al, 2019, Scientific Reports CrossRef
16. Bioactive Components Having Antimicrobial and Anticancerous Properties: A Review
    Anuradha Singh et al, 2023, Bioactive Components CrossRef
17. Targeting Cell Cycle Proteins in Brain Cancer
    Isabelle Ferry et al, 2018, Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy CrossRef
18. Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation
    Alpesh Shah et al, 2024, Bioorganic Chemistry CrossRef